19557511

Summary
Title
Polar lipid remodeling and increased sulfatide expression are associated with the glioma therapeutic candidates, wild type p53 elevation and the topoisomerase-1 inhibitor, irinotecan.
Authors
  • He H
  • Nilsson CL
  • Emmett MR
  • Ji Y
  • Marshall AG
  • Kroes RA
  • Moskal JR
  • Colman H
  • Lang FF
  • Conrad CA
Source
Glycoconj J
Publication Date
2010 Jan
PubMed ID
19557511

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024